{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:04:27Z","timestamp":1789596267422,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":650,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Orchid, fighting male cancer Barts and the London Charity"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41379-020-00717-2","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T07:03:18Z","timestamp":1608015798000},"page":"834-841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0537-5894","authenticated-orcid":false,"given":"Glenda","family":"Scandura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0256-0074","authenticated-orcid":false,"given":"Thomas","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Alifrangis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Shamash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5474-8696","authenticated-orcid":false,"given":"Daniel M.","family":"Berney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-00717-2_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/andr.293","article-title":"International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007","volume":"3","author":"Trabert","year":"2015","journal-title":"Andrology"},{"key":"10.1038\/s41379-020-00717-2_bib2","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-00717-2_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2016.07.013","article-title":"Conditional risk of relapse in surveillance for clinical stage I testicular cancer","volume":"71","author":"Nayan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-020-00717-2_bib4","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-00717-2_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/his.13667","article-title":"Pathological risk factors for higher clinical stage in testicular seminomas","volume":"73","author":"Trevino","year":"2018","journal-title":"Histopathology."},{"key":"10.1038\/s41379-020-00717-2_bib6","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1200\/JCO.2014.56.8006","article-title":"Treatment options for stage i nonseminoma","volume":"32","author":"Feldman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-00717-2_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.eururo.2010.12.010","article-title":"Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience","volume":"59","author":"Sturgeon","year":"2011","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-020-00717-2_bib8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0959-8049(00)00442-1","article-title":"Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse","volume":"37","author":"Alexandre","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-020-00717-2_bib9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.1995.13.5.1188","article-title":"Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience","volume":"13","author":"Gels","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-00717-2_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-020-00717-2_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/his.12657","article-title":"Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists","volume":"67","author":"Berney","year":"2015","journal-title":"Histopathology."},{"key":"10.1038\/s41379-020-00717-2_bib12","unstructured":"James DB, Mary KG, Christian W. TNM classification of malignant tumours. 8th ed. Wiley Blackwell, 2017."},{"key":"10.1038\/s41379-020-00717-2_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.13200","article-title":"UICC drops the ball in the 8th edition TNM staging of urological cancers","volume":"71","author":"Delahunt","year":"2017","journal-title":"Histopathology."},{"key":"10.1038\/s41379-020-00717-2_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/s41379-020-00717-2_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 Update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-020-00717-2_bib16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.6004\/jnccn.2015.0092","article-title":"Testicular cancer, version 2.2015","volume":"13","author":"Motzer","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/s41379-020-00717-2_bib17","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up","volume":"29","author":"Honecker","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-00717-2_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/bju.14967","article-title":"Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis","volume":"125","author":"Blok","year":"2019","journal-title":"BJU Int"},{"key":"10.1038\/s41379-020-00717-2_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/modpathol.2012.189","article-title":"Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ. cell tumors","volume":"26","author":"Yilmaz","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-00717-2_bib20","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1200\/JCO.2003.01.094","article-title":"Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review","volume":"21","author":"Vergouwe","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-00717-2_bib21","unstructured":"Berney D, Verrill C. Standards and datasets for reporting cancers. Dataset for histopathological reporting of testicular neoplasms. 2020. https:\/\/www.rcpath.org\/uploads\/assets\/6c10e277-2d7f-4e2a-b2db6d424cb0825a\/G046-Dataset-for-the-histopathological-reporting-of-testicular-neoplasms.pdf."},{"key":"10.1038\/s41379-020-00717-2_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2003.07.169","article-title":"Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial","volume":"21","author":"Albers","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4 Pt 1","key":"10.1038\/s41379-020-00717-2_bib23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.juro.2006.06.012","article-title":"Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?","volume":"176","author":"Divrik","year":"2006","journal-title":"J Urol"},{"key":"10.1038\/s41379-020-00717-2_bib24","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/annonc\/mdv180","article-title":"A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion","volume":"26","author":"Lago-Hernandez","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-00717-2_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1699-0463.1990.tb01047.x","article-title":"Histopathological features in stage I non-seminomatous testicular germ cell tumours correlated to relapse. Danish Testicular Cancer Study Group","volume":"98","author":"Jacobsen","year":"1990","journal-title":"APMIS."},{"key":"10.1038\/s41379-020-00717-2_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1464-410X.2003.04270.x","article-title":"A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours","volume":"92","author":"Atsu","year":"2003","journal-title":"BJU Int"},{"key":"10.1038\/s41379-020-00717-2_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-018-1090-y","article-title":"Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections","volume":"35","author":"Spratt","year":"2018","journal-title":"Med Oncol"},{"key":"10.1038\/s41379-020-00717-2_bib28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00345-016-1964-6","article-title":"Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors","volume":"35","author":"Gumus","year":"2017","journal-title":"World J Urol"},{"key":"10.1038\/s41379-020-00717-2_bib29","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0022-5347(05)65527-9","article-title":"Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients","volume":"166","author":"Roeleveld","year":"2001","journal-title":"J Urol"},{"key":"10.1038\/s41379-020-00717-2_bib30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1097-0142(19880915)62:6<1202::AID-CNCR2820620627>3.0.CO;2-S","article-title":"Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone","volume":"62","author":"Dunphy","year":"1988","journal-title":"Cancer."},{"key":"10.1038\/s41379-020-00717-2_bib31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00345-014-1454-7","article-title":"Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors","volume":"33","author":"Li","year":"2015","journal-title":"World J Urol"},{"key":"10.1038\/s41379-020-00717-2_bib32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7314\/APJCP.2014.15.2.831","article-title":"Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors","volume":"15","author":"Yetisyigit","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1038\/s41379-020-00717-2_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrurol.2016.164","article-title":"Management of stage I testicular germ cell tumours","volume":"13","author":"Chovanec","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1038\/s41379-020-00717-2_bib34","doi-asserted-by":"crossref","first-page":"e033713","DOI":"10.1136\/bmjopen-2019-033713","article-title":"Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study","volume":"9","author":"Wagner","year":"2019","journal-title":"BMJ Open"},{"key":"10.1038\/s41379-020-00717-2_bib35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00345-013-1194-0","article-title":"Prediction of metastatic status in non-seminomatous testicular cancer","volume":"32","author":"Ruf","year":"2014","journal-title":"World J Urol"},{"key":"10.1038\/s41379-020-00717-2_bib36","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/PAS.0000000000000844","article-title":"Reporting and staging of testicular germ cell tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations","volume":"41","author":"Verrill","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-00717-2_bib37","first-page":"560","article-title":"Challenges with the 8th edition of the AJCC Cancer Staging Manual for Breast, Testicular, and Head and Neck Cancers","volume":"17","author":"Sahin","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/s41379-020-00717-2_bib38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/PAS.0000000000001008","article-title":"The significance of spermatic cord involvement by testicular germ cell tumors: should we be staging discontinuous invasion from involved lymphovascular spaces differently from direct extension?","volume":"42","author":"Sanfrancesco","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-00717-2_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2559.2005.02207.x","article-title":"The continued value of central histopathological review of testicular tumours","volume":"47","author":"Delaney","year":"2005","journal-title":"Histopathology."},{"key":"10.1038\/s41379-020-00717-2_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clgc.2016.05.005","article-title":"Value of supraregional multidisciplinary review for the contemporary management of testicular tumors","volume":"15","author":"Purshouse","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1038\/s41379-020-00717-2_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.humpath.2019.10.004","article-title":"Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition","volume":"94","author":"Scandura","year":"2019","journal-title":"Hum Pathol"}],"updated-by":[{"DOI":"10.1016\/j.modpat.2023.100105","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000}}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-00717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-00717-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-00717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T14:30:17Z","timestamp":1675780217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222006494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0893395222006494"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-00717-2","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.modpat.2023.100105","asserted-by":"object"}]},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-00717-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}